Clinical Trials List
2022-01-31 - 2028-09-30
Phase III
Recruiting5
ICD-10C14.0
Malignant neoplasm of pharynx, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9149.0
Malignant neoplasm of pharynx, unspecified
-
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/15
Investigators and Locations
Co-Principal Investigator
- 王正旭 Division of Hematology & Oncology
- 葉光揚 無
- Pei-Hung Chang Division of Hematology & Oncology
- HANG HUONG LING 無
- 黃士銘 無
- Shih-Wei Yang 無
- 楊濟匡 無
- 陳耀亮 無
- 黃郁潔 無
- 李宜展 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Chi Wang 無
- 王景平 無
- 林玟君 無
- 劉時安 無
- 鄭皓升 無
- 謝合原 無
- 李立慈 Division of Oral and Maxillofacial Surgery
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- 連凱華 Division of Oral and Maxillofacial Surgery
- Cheng-Lun Lai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JANG-JAER LEE Division of General Dentistry
- 林玫君
- 林鴻穎
- 柯政郁
- RUEY-LONG HONG
- Pei-Jen Lou
- HSIN-MING CHEN
- 陳俊男
- 陳婉瑜
- YA-FANG CHEN
- 陳贈成
- 章浩宏
- 黃彥霖
- HUAI-CHENG HUANG
- Tsung-Lin Yang
- 廖斌志
- 鄭世榮
- 王成平
- 王駿瑋
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
500 participants
